#

+91-9811715635

  • #
  • #
  • #
#
Global Albumin Market Report, Global Albumin Market: Size, Trends & Forecasts (2018-2022)

Global Albumin Market: Size, Trends & Forecasts (2018-2022)

Publish Date:Jan 2018
No. of Pages:53

Format : Adobe Reader (PDF) Instant delivery

US$ 800.00

Scope of the Report

The report entitled “Global Albumin Market: Size, Trends & Forecasts (2018-2022)”, provides analysis of the global albumin market, with detailed analysis in terms of value, volume and per capita consumption of Albumin in various countries worldwide. Also, an analysis of major players in the market in terms of volume of albumin supplied by them has also been done.

The report also includes a brief regional analysis of China albumin market. Under competitive landscape, different players present in the albumin market have been compared on the basis of market share.

Moreover, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall albumin market has also been forecasted for the years 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

CSL Limited, Shire Plc, Grifols SA and Octapharma AG are some of the key players operating in the global albumin market whose company profiling is done in the report. In this segment of the report, business overview, financial overview and the business strategies of the companies are provided.

Company Coverage

CSL Limited
Shire Plc
Grifols SA
Octapharma AG

Executive Summary

Blood plasma is the liquid constituent of the blood. It is responsible for holding the blood cells in whole blood suspension. Albumin is one of the segments of blood plasma while the others are immunoglobulin, alpha1 and factor 8 proteins.

Albumin is a globular protein soluble in water and its production takes place in the liver. It is an important constituent of blood plasma. Blood plasma Albumin is used for treating patients with blood related health issues such as hypoalbuminemia (low albumin), hypovolemic (low blood volume), acute respiratory distress syndrome (ARDS), burns, nephrosis, renal dialysis, acute liver failure, cardiopulmonary bypass surgery and hemolytic disease of the newborn.

The albumin can be segmented on the basis of type and applications. On the basis of type, the albumin can be split into human serum albumin and recombinant serum albumin. On the basis of application, albumin can be sub segmented into four categories such as cell culture, vaccines, blood volumizer and drug delivery.

The global albumin market is anticipated to grow at a healthy rate during the forecast period (2018-2022). The market is supported by various growth drivers such as spike in ageing population, boost in number of plasma donation centers and increasing use of albumin for the treatment of Alzheimer patients. However, the high pricing pressure faced by the major players operating in the global albumin market is a major challenge.

However, acceleration in use of albumin for non therapeutic applications, ease of packaging and potential growth opportunities in China are some of the latest trends existing in the market.

1. Executive Summary

2. Introduction

2.1 Albumin: An Overview 
2.2 Serum Albumin: An Overview 
2.3 Global Albumin Market Segments

2.3.1 On the Basis of Type
2.3.2 On the Basis of Application

3. Global Market Analysis

3.1 Global Blood Plasma Market: An Analysis 

3.1.1 Global Blood Plasma Market by Value 
3.1.2  Global Blood Plasma Market by Segments

3.2 Global Albumin Market: An Analysis 

3.2.1 Global Albumin Market by Value 
3.2.2 Global Albumin Market by Volume
3.2.3 Global Albumin Market by Per Capita Consumption
3.2.4 Global Albumin Market Volume: Players Analysis

3.3 China Albumin Market: An Analysis 

3.3.1 China Albumin Market by Value

4. Market Dynamics 

4.1 Growth Drivers 
4.1.1 Spike in Ageing Population 
4.1.2 Increase in Number of Plasma Donation Centers 
4.1.3 Use in Alzheimer Patients 

4.2 Challenges 
4.2.1 High Pricing Pressure 

4.3 Market Trends 
4.3.1 Ease of Packaging 
4.3.2 Strong Growth Potential in China 
4.3.3 Non Therapeutic Applications of Albumin

5. Competitive Landscape 

5.1 Global Plasma Market Players by Share 
5.2 Global Albumin Market Players by Share 
5.3 Global Albumin Market: Player Analysis
5.3.1 Grifols Share Comparison

6. Company Profiles 

6.1 CSL Limited 
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy

6.2 Shire Plc 
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy

6.3 Grifols SA 
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy

6.4 Octapharma AG 
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategy
Figure 1: Global Albumin Market Segments On the Basis of Type and Application
Figure 2: Global Blood Plasma Market by Value; 2016-2017 (US$ Billion)
Figure 3: Global Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 4: Global Blood Plasma Market by Segments; 2017 (Percentage,%)
Figure 5: Global Albumin Market by Value; 2016-2017 (US$ Billion)
Figure 6: Global Albumin Market by Value; 2018-2022 (US$ Billion)
Figure 7: Global Albumin Market by Volume; 2013-2017 (Million Grams)
Figure 8: Albumin Consumption Per Capita by Country; 2016 (Grams/ 1000 habitants)
Figure 9: Global Albumin Market Volume: Shire and CSL Behring; 2013-2017 (Million Grams)
Figure 10: Global Albumin Market Volume: Grifols and CBPO;2013-2017 (Million Grams)
Figure 11: China Albumin Market by Value; 2016-2017 (US$ Billion)
Figure 12: China Albumin Market by Value; 2018-2022 (US$ Billion)
Figure 13: Global Ageing Population (Population Age 65 Years and Above); 2012-2016 (Millions)
Figure 14: Number of Plasma Donation Centers in the US; 2013-2017
Figure 15: Global Plasma Market Players by Share; 2016 (Percentage,%)
Figure 16 : Global Albumin Market Players by Share; 2013 (Percentage,%)
Figure 17: Global Albumin Market Players by Share; 2017 (Percentage,%)
Figure 18: CSL Limited Revenues 2013-2017 (US$ Billion)
Figure 19: CSL Limited Revenues by Segments; 2017 (Percentage,%)
Figure 20: Shire Plc Revenues; 2012-2016 (US$ Billion)
Figure 21: Shire Plc Revenues by Segments; 2016 (Percentage,%)
Figure 22: Grifols Revenues; 2012-2016 (US$ Billion)
Figure 23: Grifols Revenues by Segments; 2016 (Percentage,%)
Figure 24: Octapharma Revenues; 2012-2016 (US$ Billion)
Table 1: Global Albumin Market Segments on the Basis of Type
Table 2: Global Albumin Market Segments on the Basis of Application
Table 3: Grifols Market Share in Various Proteins; 2011-2016 (Percentage,%)